We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
8626
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$54K ﹤0.01%
24,900
+11,900
+92% +$29.5K
HPJ
8627
CALL
DELISTED
Highpower International Inc
HPJ
$54K ﹤0.01%
20,100
+1,000
+5% +$2.88K
LITS
8628
CALL
Lite Strategy Inc
LITS
$30.9M
$53K ﹤0.01%
+620
New +$50.7K
MVIS icon
8629
PUT
Microvision
MVIS
$53M
$53K ﹤0.01%
2,927
+1,167
+66% +$18.3K
NMM icon
8630
CALL
Navios Maritime Partners
NMM
$2.34B
$53K ﹤0.01%
2,027
+654
+48% +$19.2K
URG
8631
Ur-Energy
URG
$541M
$53K ﹤0.01%
66,581
+13,212
+25% +$10K
PDLI
8632
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
$53K ﹤0.01%
20,200
+3,800
+23% +$9.33K
STGW icon
8633
CALL
Stagwell
STGW
$2.26B
$52K ﹤0.01%
+12,500
New +$61.1K
CORV
8634
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$52K ﹤0.01%
+13,005
New +$57.3K
EVK
8635
DELISTED
Ever-Glory International Group, Inc.
EVK
$52K ﹤0.01%
15,711
+2,322
+17% +$8.01K
MBII
8636
DELISTED
Marrone Bio Innovations, Inc.
MBII
$51K ﹤0.01%
+27,899
New +$54.1K
ZN
8637
DELISTED
Zion Oil & Gas, Inc.
ZN
$51K ﹤0.01%
40,026
+9,910
+33% +$23.1K
NWY
8638
DELISTED
New York & Co Inc
NWY
$51K ﹤0.01%
13,146
-1,568
-11% -$7.37K
KDMN
8639
DELISTED
Kadmon Holdings, Inc.
KDMN
$50K ﹤0.01%
+15,141
New +$53.7K
TUES
8640
DELISTED
Tuesday Morning Corp
TUES
$50K ﹤0.01%
15,647
+1,677
+12% +$4.96K
CCIH
8641
DELISTED
Chinacache International Holdings Ltd
CCIH
$50K ﹤0.01%
+44,929
New +$53.2K
PME
8642
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$50K ﹤0.01%
+22,162
New +$56.8K
EFOI icon
8643
Energy Focus
EFOI
$19.2M
$49K ﹤0.01%
680
+133
+24% +$10.1K
MCEP
8644
CALL
DELISTED
Mid-Con Energy Partners, LP
MCEP
$49K ﹤0.01%
1,625
+420
+35% +$13.5K
ACHN
8645
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$49K ﹤0.01%
+13,300
New +$39.6K
FBIO icon
8646
Fortress Biotech
FBIO
$92.7M
$48K ﹤0.01%
+2,002
New +$64.1K
NMR icon
8647
PUT
Nomura Holdings
NMR
$28.7B
$48K ﹤0.01%
+10,100
New +$47.8K
SIOX
8648
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$48K ﹤0.01%
2,476
-15,180
-86% -$276K
CSLT
8649
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$48K ﹤0.01%
+17,900
New +$63.2K
CNET icon
8650
PUT
ZW Data Action Technologies
CNET
$4.95M
$46K ﹤0.01%
1,340
+795
+146% +$33.4K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.